¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cardiac shunt"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • shunt
    1. Áö¸§±æ, »çÀÕ±æ 2. ¼ÇÆ®, Áö¸§
  • shunt circuit
    ¼ÇƮȸ·Î
  • shunt effect
    Áö¸§±æÈ¿°ú, ¼ÇƮȿ°ú
  • shunt malfunction
    Áö¸§±æ±â´ÉºÒ·®, ¼ÇÆ®±â´ÉºÒ·®
  • shunt operation
    ¼ÇÆ®¼ö¼ú, Áö¸§¼ú
  • ventriculoatrial shunt
    ³ú½Ç½É¹æ¼ÇÆ®
  • ventriculoperitoneal shunt
    ³ú½Çº¹°­¼ÇÆ®
  • advanced cardiac life support
    »ó±Þ½ÉÀå¼Ò»ý¼ú, Àü¹®½ÉÀå¼Ò»ý¼ú
  • absolute cardiac dullness
    Àý´ë½ÉÀåµÐŹÀ½
  • cardiac
    1. ½ÉÀå- 2. µé¹®-, ºÐ¹®- 3. ½ÉÀ庴ȯÀÚ
  • cardiac arrest
    ½ÉÀåÁ¤Áö
  • cardiac arrhythmia
    ½ÉÀåºÎÁ¤¸Æ
  • cardiac asthma
    ½ÉÀåõ½Ä
  • cardiac beriberi
    ½ÉÀå°¢±â
  • cardiac catheterization
    ½ÉÀåµµ°ü»ðÀÔ, ½ÉÀåÄ«Å×ÅÍ»ðÀÔ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cardiac pump
    ½ÉÀåÆßÇÁ
  • cardiac pacemaker
    ½ÉÀå¹Úµ¿Á¶À²±â
  • cardiac rate
    (¢¡heart rate) ½ÉÀå¹Úµ¿¼ö
  • cardiac temponade
    ½ÉÀå´­¸²Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • subarachnoid ureteral shunt
    °Å¹Ì¸·¹Ø¿ä°üÁö¸§±æ, °Å¹Ì¸·¹Ø¿ä°üÁö¸§¼ú
  • subduro-atrial shunt
    ³ú°æ¸·¹Ø½É¹æÁö¸§¼ú
  • subduro-peritoneal shunt
    ³ú°æ¸·¹Ø¹è¾ÈÁö¸§¼ú
  • ventriculoatrial shunt
    ³ú½Ç½É¹æÁö¸§¼ú
  • ventriculocaval shunt
    ³ú½Ç»ó´ëÁ¤¸ÆÁö¸§¼ú
  • ventriculosubarachnoid shunt
    ³ú½Ç°Å¹Ì¸·¹ØÁö¸§¼ú
  • absolute cardiac dullness
    Àý´ë½ÉÀåµÐŹÀ½
  • cardiac arrest
    ½ÉÀåÁ¤Áö
  • cardiac arrhythmia
    ½ÉÀåºÎÁ¤¸Æ
  • cardiac asthma
    ½ÉÀåõ½Ä
  • cardiac beriberi
    ½ÉÀå°¢±â
  • primitive cardiac bulb
    ¿ø½Ã½ÉÀ寨´ë
  • cardiac
    ½ÉÀå-, µé¹®-, ½ÉÀ庴ȯÀÚ
  • cardiac chamber
    (¢¡cardiac ventricle) ½É½Ç
  • cardiac cirrhosis
    ½ÉÀå°£°æÈ­(Áõ)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • great cardiac vein
    Å«½ÉÀåÁ¤¸Æ
  • heart loop =cardiac l.
    ½ÉÀå·ç¿ìÇÁ.
  • heart stoppage =cardiac arrest
    ½É(¹Ú)Á¤Áö(ãýÚÑïÎò­).
  • heart stoppage =cardiac arrest
    ½É(¹Ú)Á¤Áö(ãýÚÑïÎò­).
  • hypertrophy, cardiac
    ½ÉÀåºñÈÄ.
  • impure cardiac sound
    ºÒ¼ø½ÉÀ½.
  • inferior cervical cardiac branches
    ¾Æ·¡¸ñ½ÉÀå°¡Áö
  • inferior cervical cardiac nerve
    ¾Æ·¡¸ñ½ÉÀå½Å°æ
  • primitive cardiac bulb
    ¿ø½Ã½ÉÀ寨´ë
  • reduction of cardiac work load
    ½ÉÀÛ¾÷·®ÀÇ °æ°¨(ãýíÂåöåÖ¡­ÌîÊõ).
  • relative cardiac dullness
    »ó´ë½ÉŹÀ½°è(ßÓÓßãýöúëåÍ£).
  • relative cardiac dullness
    »ó´ë½ÉŹÀ½°è(ßÓÓßãýöúëåÍ£)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • right to left shunt
    Á¿ì´Ü¶ô(ñ§éÓÓ­Õ©).
  • right to left shunt
    Á¿ì´Ü¶ô(ñ§éÓÓ­Õ©)
  • right-to-left shunt
    ¿ìÁÂ¼ÇÆ®(¿ìÁ¡­)
  • shunt
    ¼ÇÆ®(¡­), ´Ü¶ô(Ó­Õ©), ¹®ÇÕ(Ùüùê)
  • shunt =short circuit
    ¼ÇÆ®, ´Ü¶ô (Ó­Õ©).
  • shunt effect
    ¼ÇƮȿ°ú, ´Ü¶ôÈ¿°ú(¡­üùÍý).
  • shunt equation
    ¼ÇÆ®¹æÁ¤½Ä.
  • shunt operation
    ´Ü¶ô¼ö¼ú, ¹®ÇÕ¼ö¼ú.
  • splenorenal shunt
    ºñ½ÅÁ¤¸Æ¹®ÇÕ¼ú(ºñ½ÅÁ¤¸Æ¹®ÇÕ¼ú).
  • subarachnoid ureteral shunt
    °Å¹Ì¸·Çϰ­´¢°ü´Ü¶ô(¡­Ë·èñηӭթ).
  • subarachnoid ureteral shunt
    °Å¹Ì¸·Çϰ­´¢°ü´Ü¶ô(¡­Ë·èñηӭթ)
  • transjugular intrahepatic portosystemic shunt
    °æ°æÁ¤¸Æ°£³»¹®¸ÆÁ¤¸Æ´Ü¶ô¼ú
  • ventriculoatrial shunt
    ³ú½Ç½É¹æ´Ü¶ô(ÒàãøãýÛ®Ó­Õ©).
  • ventriculoauricular shunt
    ³ú½Ç½ÉÀÌ(¡­ãýì¼)´Ü¶ô.
  • ventriculocaval shunt
    ³ú½Ç»ó´ëÁ¤¸Æ´Ü¶ô(¼ú)(Òàãøß¾ÓÞð¡ØæÓ­Õ©âú).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Cardiac prominence
    ½ÉÀåÀ¶±â
    [¿¾ ¿ë¾î] ½ÉÀåÀ¶±â
  • Cardiac impression
    ½ÉÀåÀÚ±¹
    [¿¾ ¿ë¾î] ½É¾ÐÈç
  • Cardiac conducting system
    ½ÉÀåÀüµµ°èÅë
    [¿¾ ¿ë¾î] ½ÉÀåÀÚ±ØÀüµµ°è
  • Cardiac veins
    ½ÉÀåÁ¤¸Æ
    [¿¾ ¿ë¾î] ½ÉÀåÁ¤¸Æ
  • Inferior cervical cardiac branches
    ¾Æ·¡¸ñ½ÉÀå°¡Áö
    [¿¾ ¿ë¾î] Çϰæ½ÉÀåÁö
  • Inferior cervical cardiac nerve
    ¾Æ·¡¸ñ½ÉÀå½Å°æ
    [¿¾ ¿ë¾î] Çϰæ½ÉÀå½Å°æ
  • Primitive cardiac bulb
    ¿ø½Ã½ÉÀ寨´ë
    [¿¾ ¿ë¾î] ¿ø½Ã½É±¸
  • Cardiac gland
    À§µé¹®»ù
    [¿¾ ¿ë¾î] ºÐ¹®¼±
  • Secretory cell of cardiac gland
    À§µé¹®»ù¼¼Æ÷
    [¿¾ ¿ë¾î] ºÐ¹®¼±¼¼Æ÷
  • Superior cervical cardiac branches
    À§¸ñ½ÉÀå°¡Áö
    [¿¾ ¿ë¾î] »ó°æ½ÉÀåÁö
  • Superior cervical cardiac nerve
    À§¸ñ½ÉÀå½Å°æ
    [¿¾ ¿ë¾î] »ó°æ½ÉÀå½Å°æ
  • Small cardiac vein
    ÀÛÀº½ÉÀåÁ¤¸Æ
    [¿¾ ¿ë¾î] ¼Ò½ÉÀåÁ¤¸Æ
  • Middle cervical cardiac nerve
    Áß°£¸ñ½ÉÀå½Å°æ
    [¿¾ ¿ë¾î] Áß°æ½ÉÀå½Å°æ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cardiac failure
    ½ÉºÎÀüÁõ
  • cardiac gated MR study
    ½ÉÀ嵿±âÀÚ±â°ø¸í°Ë»ç
  • cardiac gating
    ½ÉÀ嵿±â
  • cine cardiac magnetic resonance imaging
    ¿µÈ­½ÉÀåÀÚ±â°ø¸í¿µ»ó
  • multiphase cardiac imaging
    ´ÙÁßÀ§»ó ½ÉÀ念»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HMP Shunt Hexose Mono-Phosphate Shunt
LP shunt Lumbo-Peritoneal shunt
VA shunt Ventriculo-Atrial shunt
VP shunt Ventriculo-Peritoneal shunt
VU shunt Ventriculo-Ureteral shunt
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TIPS Transjugular Intrahepatic Portosystemic Shunt
TIPSS Transjugular Intrahepatic Portosystemic Stent Shunt
PSS porto-systemic shunt
ACI Acute cardiac ischemia
ACLS Advanced Cardiac Life Support
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cardiac assist
    ½É º¸Á¶
    ½ÉÀåÀ» º¸Á¶ÇÏ´Â °Í.
  • cardiac asthma
    ½ÉÀμº õ½Ä
    ÁÂ½É½Ç ºÎÀü°ú °°Àº ½ÉÀå Áúȯ¿¡ ¼ö¹ÝÇÏ¿© ÀϾ´Â ¹ßÀÛ¼º È£Èí °ï¶õ.
  • cardiac branch
    ½ÉÀå °¡Áö, ½ÉÀåÁö
    ½ÉÀå¿¡¼­ ºÐÇÒ ¶Ç´Â ÆÄ»ýÇÑ °Í.
  • cardiac catheter
    ½ÉÀå Ä«Å×ÅÍ
    X¼± Åõ½ÃÇÏ¿¡ ¸»ÃÊÇ÷°üÀ» ÅëÇÏ¿© ½É¹æ, ½É½Ç¿¡ »ðÀÔÇϵµ·Ï ¸¸µç Ư¼ö Ä«Å×ÅÍ.
  • cardiac chamber
    ½É½Ç
    µ¿ÀǾî=cardiac ventricle.
  • cardiac compensation
    ½ÉÀå ´ë»ó
    ½ÉÀå°ú °ü·ÃµÈ Áõ»óÀ» ³ªÅ¸³»Áö ¾Ê°Ô ½ÉÀåÀÌ ÀûÀýÇÑ Ç÷·ù·®À» À¯ÁöÇϰí ÀÖ´Â °Í.
  • cardiac contraction
    ½ÉÀå ¼öÃà
    ½ÉÀå±ÙÀ°ÀÇ ¼öÃà°ú °ü·ÃÇÏ¿© ´ÜÃà°ú ±äÀåÀÇ ¹ß»ýÀ» ¶æÇÑ´Ù.
  • cardiac cycle
    ½ÉÀå ÁÖ±â, ½É ÁÖ±â
    ½É¹æ°ú ½É½ÇÀº ½Ã°£ÀûÀ¸·Î µ¿½Ã´Â ¾Æ´ÏÁö¸¸ ¼öÃà°ú È®ÀåÀ» °ÅµìÇϰí ÀÖ°í, ÀÌ ÁÖ±âÀûÀΠȰµ¿ÀÌ ½É¹Úµ¿ÀÌ°í ½É¹Úµ¿ÀÇ Áֱ⸦ ½ÉÁÖ±â¶ó°í ÇÑ´Ù.
  • cardiac decompensation
    ½É´ë»ó ºÎÀü, ½É½ÇÁ¶, ½ÉÀå ½ÇÁ¶, ½É ±â´É ´ë»ó ºÎÀü
    ½ÉÀåÀÌ ´ë»ó¼º ±â´É Áï ºñ´ë³ª ºó¸Æ µîÀ¸·Î ÃæºÐÈ÷ ¼øÈ¯ Ç÷·ù·®À» À¯ÁöÇÏÁö ¸øÇÏ´Â »óÅÂ.
  • cardiac depressant
    ½É ¾ïÁ¦Á¦
    ½É¹Ú ¼öÀÇ °¨¼Ò¿Í ½ÉÀå ¼öÃà·ÂÀÇ ÀúÇϸ¦ ÀÏÀ¸Å°´Â ¾à¹°.
  • cardiac disorder
    ½ÉÀå Áúȯ
    ½ÉÀåÀÇ Àå¾Ö, ºÎÁ¶È­, Áúȯ. ±â´ÉÀÇ È¥¶õ ¶Ç´Â ºñÁ¤»ó.
  • cardiac dysfunction
    ½É ±â´É Àå¾Ö, ½ÉÀå ±â´É Àå¾Ö
    ½ÉÀåÀÇ ±â´ÉÀå¾Ö ¶Ç´Â ÀÌ»ó.
  • cardiac electrophysiology
    ½É Àü±â»ý¸®ÇÐ, ½ÉÀå Àü±â »ý¸®ÇÐ
  • cardiac failure
    ½ÉºÎÀü, ½ÉºÎÀüÁõ
    µ¿ÀǾî=heart failure. ÃæºÐÇÑ Á¤¸Æ Ãæ¸¸¾ÐÀÌ Àִµ¥µµ »ýüÀÇ ¼ö¿ä¿¡ ´ëÇØ¼­ ÀûÀýÇÑ ¼øÈ¯À» À¯ÁöÇÒ ¼ö ¾ø°Ô µÈ »óÅÂ.
  • cardiac gating
    ½ÉÀå µ¿±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
Warburg-Dickens-Horecker shunt <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate.
Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses.
In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection.
Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose.
(18 Nov 1997)
Warburg-Lipmann-Dickens-Horecker shunt <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate.
Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses.
In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection.
Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose.
(18 Nov 1997)
Warren shunt Anastomosis of the splenic end of the divided splenic vein to the left renal vein.
Synonym: distal splenorenal shunt.
(05 Mar 2000)
Waterston shunt Creation of a narrow (about 3 mm) opening between the ascending aorta and the subjacent right pulmonary artery to increase pulmonary circulation in cyanotic heart disease with decreased pulmonary flow.
(05 Mar 2000)
complications of ventriculo-peritoneal shunt <radiology> Kinking, interruption, exit from peritoneal cavity with growth, through processus vaginalis to scrotum, CSFoma, mass effect exhibited on bowel gas pattern with malfunctioning shunt, lack of movement of shunt tip with positional or temporal change, perforation of hollow viscus (e.g., bowel or bladder)
(12 Dec 1998)
portacaval shunt Surgical anastomosis between portal and systemic veins, surgical anastomosis between the portal vein and the vena cava, as in an Eck fistula.
(05 Mar 2000)
portacaval shunt, surgical Surgical portasystemic shunt between the portal vein and inferior vena cava.
(12 Dec 1998)
portasystemic shunt A shunt between any parts of the portal and systemic venous systems, including portacaval, mesocaval, splenorenal shunt's or spontaneously occurring shunt's.
(05 Mar 2000)
portasystemic shunt, surgical Surgical venous shunt between the portal and systemic circulation to effect decompression of the portal circulation. It is performed primarily in the treatment of bleeding oesophageal varices resulting from portal hypertension. Types of shunt include portacaval, splenorenal, mesocaval, splenocaval, left gastric-caval (coronary-caval), portarenal, umbilicorenal, and umbilicocaval.
(12 Dec 1998)
portasystemic shunt, transjugular intrahepatic A type of surgical portasystemic shunt to reduce portal hypertension with associated complications of oesophageal varices and ascites. It is performed percutaneously through the jugular vein and involves the creation of an intrahepatic shunt between the hepatic vein and portal vein. The channel is maintained by a metallic stent. The procedure can be performed in patients who have failed sclerotherapy and is an additional option to the surgical techniques of portocaval, mesocaval, and splenorenal shunts. It takes one to three hours to perform. (jama 1995;273(23):1824-30)
(12 Dec 1998)
hexose monophosphate shunt The main metabolic pathway in activated neutrophils, rendering them relatively insensitive to inhibitors of oxidative phosphorylation. Congenital deficiency of the first enzyme in the shunt, glucose 6 phosphate dehydrogenase, produces a sensitivity to infection similar to that seen in chronic granulomatous disease.
(18 Nov 1997)
Scribner shunt Connection of an artery, customarily the radial, to the cephalic vein via a short extracorporeal catheter.
(05 Mar 2000)
H shunt <surgery> A side-to-side shunt between adjacent vessels which utilises a connecting conduit.
Synonym: H graft.
(05 Mar 2000)
shunt 1. To turn to one side, to divert, to bypass.
2. <cardiology> A passage or anastomosis between two natural channels, especially between blood vessels. Such structures may be formed physiologically (for example to bypass a thrombosis) or they may be structural anomalies.
3. <surgery> A surgically created anastomosis, also, the operation of forming a shunt.
(18 Nov 1997)
shunt, left to right A term used to describe the diversion of blood from the higher pressure left side of the heart to the right side (pulmonary circuit). Can be seen in ventricular septal defect, atrial septal defect and patent ductus arteriosus (congenital at birth).
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á